MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

SciClone Pharmaceuticals Company Profile (NASDAQ:SCLN)

Consensus Ratings for SciClone Pharmaceuticals (NASDAQ:SCLN) (?)
Ratings Breakdown: 1 Sell Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $9.00 (15.53% upside)

Analysts' Ratings History for SciClone Pharmaceuticals (NASDAQ:SCLN)
Show:
DateFirmActionRatingPrice TargetActions
7/9/2015BWS FinancialDowngradeHold -> SellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/29/2015MLV & Co.Initiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2015AegisReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2014AegisSet Price TargetBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/14/2014BWS FinancialDowngradeBuy -> Hold$8.25 -> $8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/29/2014AegisReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2013AegisLower Price TargetBuy$9.00 -> $8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/25/2013AegisReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/29/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha